Final June Diabetes News Snippet Post
(Source: Diabetes Update)
Source: Diabetes Update - July 3, 2013 Category: Endocrinology Source Type: blogs
Final June Diabetes News Snippet Post
Jennysaid... The FDA is taking another look at Avandia's relationship to heart disease. http://www.forbes.com/sites/matthewherper/2013/06/04/battleground-fda-how-tomorrows-avandia-panel-could-help-shape-the-future-of-diabetes/But whatever they conclude about whether or not Avandia causes heart attacks, we know that it, like Actos, also weakens the bones over time and makes them prone to fracture, since it converts that stem cells that should become bone cells into baby fat cells.It, like Actos, also raises the chances of experiencing retinal edema--swelling in the blood vessels in your eye that can contribute to blindn...
Source: Diabetes Update - July 3, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
Big Changes in the Drug Patent World Are Good News for People with Diabetes
Several days ago the Supreme Court of the U.S. issued a decision saying that the FDA could sue drug companies that paid off generic drug makers to keep them from releasing generic versions of drugs that had gone off patent. A second decision that may be just as important for controlling the costs of drugs for people with diabetes occurred on June 18, 2013. A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug Prandimet, a combination of Prandin with metformin to be invalid, paving the way for introduction of a generic version of the medicine.MedCity Newsletter: Novo Nordisk’s diabetes drug patent...
Source: Diabetes Update - June 20, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
Major Breakthrough in Using Stem Cells to Cure A Genetic Form of Diabetes
A study just published in the Journal of Clinical Investigation describes what sounds like a very important advance in the treatment of genetically-caused diabetes.The study is iPSC-derived β cells model diabetes due to glucokinase deficiency. Haiqing Hua et. al Journal of Clinical Investigation, 2013; DOI: 10.1172/JCI67638To better understand what was done here, read Science Daily: Researchers Demonstrate Use of Stem Cells to Analyze Causes, Treatment of DiabetesThe particular form of diabetes that was studied here was MODY-2. This is a monogentic genetic form of diabetes, which means you need have only one c...
Source: Diabetes Update - June 20, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
The ADA's " Investigation " of Incretin Drugs is a Gift to the Drug Companies
(Source: Diabetes Update)
Source: Diabetes Update - June 14, 2013 Category: Endocrinology Source Type: blogs
The ADA's "Investigation" of Incretin Drugs is a Gift to the Drug Companies
You may have heard that the American Diabetes Association (ADA) had called for a review of the incretin drugs--Januvia, Onglyza, Byetta, Victoza, etc.--in response to the recent discovery, which I described HERE, that they cause abnormal patterns of growth within the pancreas of a kind that lead to both pancreatitis and cancer. The call for review can be read HERE.Sadly, this call for review has nothing to do with protecting people with diabetes, a group for whom the ADA has never had much concern, save as a source of contributions to pay the inflated salaries of its top executives.The ADA is heavily funded by drug manufac...
Source: Diabetes Update - June 14, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
Phosphate Additives Promote Hardening of the Arteries
In this study subjects who were allowed to eat only the foods supplied by the researchers were, for four weeks, fed a control diet free of any phosphate additives. Then, for the next four weeks, they were fed a diet that contained the identical amount of calories, protein, fat, and carbohydrate as the control diet but this diet was made up of foods containing inorganic phosphate additives, like American cheese, soda, and processed meats.The report explains, "The average phosphorus content of the daily menu was 979 mg during the control period and 2124 mg during the test period." After a month of eating the foods with the a...
Source: Diabetes Update - June 7, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
June Diabetes News Snippet Post
News items of interest to people with diabetes that arise during June 2013 will be posted in the comment section below. Feel free to comment if you have something substantive to add. (Source: Diabetes Update)
Source: Diabetes Update - June 5, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
May Diabetes-Related News Snippets
Conclusion: "Compared with pravastatin, treatment with higher potency statins, especially atorvastatin and simvastatin, might be associated with an increased risk of new onset diabetes."22% higher risk with Lipitor (atorvastatin) and 18 percent higher with Crestor (rosuvastatin).In mainstream press coverage, Drug company shills,, a.k.a. well known cardiologists, bend over backward to ignore this latest confirmation of a phenomenon that has been public knowledge for more than a year. The reason that statins cause diabetes may have to do with the fact that they impair the operation mitochondria--the part of the ce...
Source: Diabetes Update - June 3, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
The Ten Companies That Profit Most Heavily From Selling You Junk Carbs
I found this remarkable graphic on a web site devoted to investment strategies. The article it illustrates pointed out that investors could earn excellent returns their entire lives by investing in these companies because their products saturate the world. The graphic shows you how many brands these 10 companies control. I bet you thought many of them were separate companies. When you realize how fully junk food is controlled by a few companies, you have to ask yourself how much money these super-sized international corporations pour into making sure that the public never learns the price they pay for loading up on the cra...
Source: Diabetes Update - May 15, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
May Diabetes News Snippet Post
News items of interest to people with diabetes that come up during May 2013 will be posted in the comment section of this post. Click on "comments" Feel free to comment or point out items that you feel need discussion. All the April news snippets have now been collected and posted here: http://diabetesupdate.blogspot.com/2013/05/diabetes-news-items-posted-during-april.html (Source: Diabetes Update)
Source: Diabetes Update - May 4, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
Diabetes News Items Posted During April
This article might interest you: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580884/ It interests me because my husband has autonomic system failure from other causes (multiple system atrophy)10:22 AM, April 19, 2013 Jennysaid... Pem,Thanks! That article is very interesting indeed. It is Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. Aaron I Vinik, et al., J Diabetes Investig. 2013 January; 4(1): 4–18.Dr. Bernstein has been writing about the impact of autonomic neuropathy on people with diabetes since the 1990s. Good to see that someone else has picked up on it.Most important takeaw...
Source: Diabetes Update - May 1, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
When You Cut Carbs, Don't Raise Phosphate Levels
Recently I've been reading up on the role of phosphates in heart disease, and what I am learning has some troubling implications for people who eat low carb diets. I already knew that people who have been diagnosed with kidney disease must avoid phosphates, as they can further damage the kideny's filtration units. I'd also discovered, and blogged about, the fact that and a person's lifetime intake of the phosphates present in brown-colored sodas, both diet and regular, have been found to correlate with their likelihood of developing kidney disease. (Details HERE)But until recently, I had not realized that blood levels o...
Source: Diabetes Update - April 21, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
April Diabetes News Snippet Post
The news items collected during April are posted in the comment section of this post. You can read them and add your comments by clicking on the "Comments" link at the bottom of this post. At the end of the month all comments will be copied into this post.If you missed any of the March Diabetes News Snippets, you can find them at:http://diabetesupdate.blogspot.com/2013/03/march-diabetes-news-snippet-post.html (Source: Diabetes Update)
Source: Diabetes Update - April 1, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
FDA Approves a Highly Questionable New Diabetes Drug, Invokana
The FDA just gave its approval to the first drug in a new class of diabetes drugs, Johnson & Johnson's canagliflozin, which will be marketed in the U.S. as Invokana.New York Times: FDA Approves a New Diabetes Drug From J.&J. (May require subscription)Reuters: U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozinThis class of drugs, the sodium-glucose co-transporter-2 (SGLT2) inhibitors, lowers blood sugar by blocking reabsorption of glucose by the kidney and increasing its excretion in urine. The manufacturer also claims that it causes weight loss--always a potent selling point for a diabetes drug.As...
Source: Diabetes Update - March 31, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
